Your browser doesn't support javascript.
loading
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
Antony, Jane; Zanini, Elisa; Kelly, Zoe; Tan, Tuan Zea; Karali, Evdoxia; Alomary, Mohammad; Jung, Youngrock; Nixon, Katherine; Cunnea, Paula; Fotopoulou, Christina; Paterson, Andrew; Roy-Nawathe, Sushmita; Mills, Gordon B; Huang, Ruby Yun-Ju; Thiery, Jean Paul; Gabra, Hani; Recchi, Chiara.
Afiliação
  • Antony J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Zanini E; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Kelly Z; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, Singapore, Singapore.
  • Tan TZ; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Karali E; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Alomary M; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Jung Y; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Nixon K; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Cunnea P; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Fotopoulou C; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Paterson A; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Roy-Nawathe S; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Mills GB; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Huang RY; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, UK.
  • Thiery JP; Division of Basic Science Research, Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gabra H; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Recchi C; Department of Obstetrics and Gynecology, National University Health System, Singapore, Singapore.
EMBO Rep ; 19(8)2018 08.
Article em En | MEDLINE | ID: mdl-29907679
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Moléculas de Adesão Celular / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Proteínas Supressoras de Tumor / Proteínas Tirosina Fosfatases Classe 5 Semelhantes a Receptores Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Moléculas de Adesão Celular / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Proteínas Supressoras de Tumor / Proteínas Tirosina Fosfatases Classe 5 Semelhantes a Receptores Idioma: En Ano de publicação: 2018 Tipo de documento: Article